Compare Oscar Health Inc (OSCR) vs Vanguard Growth Index Fund ETF (VUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Vanguard Growth Index Fund ETF — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Vanguard Growth Index Fund ETF trades at $91.97 (market cap $384.60B). The key difference: Vanguard Growth Index Fund ETF is far larger — about 37.6× Oscar Health Inc's market cap, and Vanguard Growth Index Fund ETF is more actively traded (5,662,307 versus 4,123,394). Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Vanguard Growth Index Fund ETF for 47 Days on average.
| OSCR | VUG | |
|---|---|---|
Market Cap | $10.22B | $384.60B |
Volume | 4,123,394 | 5,662,307 |
Sector | Health | Sector/Thematic |
52-Week High | $33.81 | $92.64 |
52-Week Low | $10.85 | $70.00 |
Typical Hold Time | 15 Days | 47 Days |
Enterprise Value | $6.57B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
VUG trades at $91.97, down 0.49% with a bullish technical signal supported by moving averages. The ETF holds dominant positions in mega-cap tech stocks including Nvidia, Apple, and Microsoft, which comprise over 36% of holdings. Recent financial media coverage highlights VUG's historical annual returns averaging 11-12% since its 2004 inception, positioning it as a long-term growth vehicle for investors with multi-decade horizons.
The outlook remains positive for long-term investors seeking growth exposure, though concentration in technology stocks presents sector-specific risks. Current technical levels show support at $89-91 with resistance at $92-94. The neutral oscillator readings suggest potential for consolidation near current levels before further directional movement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Vanguard Growth Index Fund ETF
VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →
